Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Completed 1Approved for marketing 1

Sponsor Class

OTHER 3

Study Type

Observational 1Interventional 1Expanded_access 1

Sponsor

Cancer Type

Sarcoma 6Other hematologic neoplasm 3Lymphoid 2Other 1Genitourinary 1

Conditions

Osteosarcoma 3Renal Insufficiency 2Lymphoma 2Leukemia 2Hematologic Neoplasms 2Water Intoxication 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Acute Kidney Injury 1

Interventions

glucarpidase 3tanespimycin 2Psychiatric Rehabilitation 2Methotrexate 2Leucovorin 2trimetrexate glucuronate 1ixabepilone 1gamma-Glutamyl Hydrolase 1entinostat 1cc-486 1Zoledronic Acid 1Vincristine 1Therapeutics 1Thalidomide 1Quality of Life 1Pentetic Acid 1Patient Reported Outcome Measures 1Palliative Care 1Nutritional Support 1Molecular Diagnostic Techniques 1Minocycline 1MLN 8237 1Injections 1Immunotherapy 1Imatinib Mesylate 1Heparin 1Gelclair 1Fentanyl 1Electroacupuncture 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Osteosarcoma × glucarpidase × Other hematologic neoplasm × Clear all
NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

BTG International Inc.

Unknown
1,000 enrolled
GenitourinaryOther hematologic neoplasmSarcoma

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

NCT00634504 2022-06-06

LVPK

BTG International Inc.

Phase 1 Completed
20 enrolled 9 charts
LymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Osteosarcoma, Renal Insufficiency

NCT00481559 2014-01-17

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

BTG International Inc.

Approved for marketing
LymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Neoplasms, Osteosarcoma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡